Piscataway, NJ, March 21, 2016– Camber Pharmaceuticals announces that it has launched Valganciclovir, USP 450 mg tablets. The drug is the generic version of Valcyte® tablets. Valganciclovir is used to treat cytomegalovirus (CMV) infection of the eye in patients with acquired immunodeficiency syndrome (AIDS).
Valganciclovir is available in 60 count bottle.
